DYN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 14.14%

Insider Buying (Last 12 Months): $1,057,280.00

Insider Selling (Last 12 Months): $6,378,024.87

Dyne Therapeutics Insider Trading History Chart

Dyne Therapeutics Share Price & Price History

^$8.94

▲ +0.26 (3.00%)

As of 07/2/2025 05:00 PM ET

Days: 30 | 90 | 365

Dyne Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/13/2025	Johanna Friedl-Naderer	Insider	Sell	143	$12.12	$1,733.16	96,057
3/11/2025	Oxana Beskrovnaya	Insider	Sell	2,153	$11.38	$24,501.14	195,840
3/11/2025	Richard William Scalzo	SVP	Sell	1,343	$11.38	$15,283.34	122,330
2/18/2025	Oxana Beskrovnaya	Insider	Sell	2,598	$13.95	$36,242.10	199,087
12/11/2024	Oxana Beskrovnaya	Insider	Sell	2,334	$28.12	$65,632.08	201,685
12/11/2024	Richard William Scalzo	SVP	Sell	1,455	$28.12	$40,914.60	127,078
11/18/2024	Carlo Incerti	Director	Sell	16,500	$28.73	$474,045.00
11/14/2024	Jason P Rhodes	Director	Sell	782	$33.10	$25,884.20	15,962
10/16/2024	Dirk Kersten	Director	Sell	23,671	$35.35	$836,769.85	99,652
9/25/2024	Dirk Kersten	Director	Sell	2,357	$35.06	$82,636.42	190,939
9/23/2024	Dirk Kersten	Director	Sell	40,831	$35.32	$1,442,150.92	193,296
9/20/2024	Dirk Kersten	Director	Sell	79,411	$36.45	$2,894,530.95	234,127
9/18/2024	Oxana Beskrovnaya	Insider	Sell	2,339	$34.55	$80,812.45	140,375
9/18/2024	Richard William Scalzo	SVP	Sell	1,390	$34.55	$48,024.50	98,568
9/18/2024	Susanna High	COO	Sell	8,976	$34.41	$308,864.16	131,636
9/4/2024	John Cox	CEO	Buy	32,000	$33.04	$1,057,280.00	8,000
6/24/2024	Susanna High	COO	Sell	10,163	$35.33	$359,058.79	148,792
6/21/2024	Susanna High	COO	Sell	29,787	$35.01	$1,042,842.87	148,792
6/12/2024	Susanna High	COO	Sell	40,000	$33.36	$1,334,400.00	148,792
6/11/2024	Oxana Beskrovnaya	Insider	Sell	2,136	$31.34	$66,942.24	147,511
6/10/2024	Richard William Scalzo	SVP	Sell	1,590	$30.23	$48,065.70	115,105
6/10/2024	Susanna High	COO	Sell	80,000	$30.24	$2,419,200.00	154,062
5/20/2024	Oxana Beskrovnaya	Insider	Sell	30,426	$32.96	$1,002,840.96	149,647
5/16/2024	Oxana Beskrovnaya	Insider	Sell	2,705	$28.27	$76,470.35	149,647
5/16/2024	Richard William Scalzo	SVP	Sell	2,588	$28.27	$73,162.76	116,695
5/16/2024	Susanna High	COO	Sell	2,738	$28.27	$77,403.26	154,062
3/11/2024	Joshua T Brumm	CEO	Sell	66,387	$25.67	$1,704,154.29	537,998
3/11/2024	Richard William Scalzo	SVP	Sell	2,672	$25.28	$67,548.16	119,283
3/11/2024	Susanna High	COO	Sell	2,292	$25.70	$58,904.40	156,800
3/11/2024	Wildon Farwell	Insider	Sell	1,585	$25.70	$40,734.50	151,590
3/7/2024	Joshua T Brumm	CEO	Sell	9,086	$25.85	$234,873.10	554,385
3/7/2024	Oxana Beskrovnaya	Insider	Sell	2,373	$25.85	$61,342.05	154,433
3/7/2024	Richard William Scalzo	SVP	Sell	2,273	$25.85	$58,757.05	121,955
3/7/2024	Susanna High	COO	Sell	1,591	$25.85	$41,127.35	186,291
2/29/2024	Jonathan Mcneill	Insider	Sell	4,268	$27.50	$117,370.00	143,618
2/29/2024	Joshua T Brumm	CEO	Sell	5,520	$27.50	$151,800.00	563,471
2/29/2024	Richard William Scalzo	SVP	Sell	3,429	$27.50	$94,297.50	124,228
2/28/2024	Jason P Rhodes	Director	Sell	190,920	$24.84	$4,742,452.80	864,487
2/28/2024	Venture Fund Xi L.P. Atlas	Major Shareholder	Sell	154,674	$24.84	$3,842,102.16	5,698,091
2/26/2024	Jason P Rhodes	Director	Sell	248,219	$23.72	$5,887,754.68	903,527
2/26/2024	Venture Fund Xi L.P. Atlas	Major Shareholder	Sell	201,095	$23.72	$4,769,973.40	6,151,467
2/23/2024	Venture Fund Xi L.P. Atlas	Major Shareholder	Sell	159,542	$22.70	$3,621,603.40	6,352,562
2/22/2024	Jason P Rhodes	Director	Sell	119,360	$22.66	$2,704,697.60	6,512,104
2/21/2024	Venture Fund Xi L.P. Atlas	Major Shareholder	Sell	184,501	$22.57	$4,164,187.57	6,631,464
2/20/2024	Jason P Rhodes	Director	Sell	169,539	$22.72	$3,851,926.08	6,815,965
2/16/2024	Venture Fund Xi L.P. Atlas	Major Shareholder	Sell	162,707	$23.14	$3,765,039.98	6,985,504
2/15/2024	Jason P Rhodes	Director	Sell	177,906	$23.89	$4,250,174.34	7,148,211
2/12/2024	Wildon Farwell	Insider	Sell	5,493	$25.07	$137,709.51	163,503
1/26/2024	Richard William Scalzo	SVP	Sell	13,000	$24.34	$316,420.00	124,228
1/26/2024	Wildon Farwell	Insider	Sell	100	$25.00	$2,500.00	168,996
1/9/2024	Dirk Kersten	Director	Buy	1,714,285	$17.50	$29,999,987.50	6,416,793
1/4/2024	Joshua T Brumm	CEO	Sell	218,536	$18.51	$4,045,101.36	584,971
1/3/2024	Oxana Beskrovnaya	Insider	Sell	45,326	$18.98	$860,287.48	176,585
1/3/2024	Richard William Scalzo	SVP	Sell	13,000	$18.81	$244,530.00	124,228
12/14/2023	Richard William Scalzo	Insider	Sell	2,376	$12.02	$28,559.52	124,228
12/11/2023	Richard William Scalzo	Insider	Sell	1,380	$10.72	$14,793.60	126,604
12/11/2023	Susanna High	COO	Sell	1,616	$10.72	$17,323.52	187,882
12/6/2023	Richard William Scalzo	Insider	Sell	1,872	$12.01	$22,482.72	127,984
12/4/2023	Richard William Scalzo	Insider	Sell	681	$12.01	$8,178.81	129,856
11/2/2023	Susanna High	COO	Sell	9,939	$7.40	$73,548.60	94,605
9/18/2023	Richard William Scalzo	Insider	Sell	1,290	$9.41	$12,138.90	40,795
9/18/2023	Susanna High	COO	Sell	2,672	$9.41	$25,143.52	104,544
9/12/2023	Susanna High	COO	Sell	1,635	$10.41	$17,020.35	107,216
9/12/2023	Wildon Farwell	Insider	Sell	1,707	$10.41	$17,769.87	89,250
6/15/2023	Richard William Scalzo	Insider	Sell	10,000	$12.03	$120,300.00	43,482
6/13/2023	Susanna High	COO	Sell	1,625	$12.43	$20,198.75	108,851
6/12/2023	Joshua T Brumm	Insider	Sell	187,748	$12.61	$2,367,502.28	253,383
6/9/2023	Joshua T Brumm	Insider	Sell	76,582	$13.34	$1,021,603.88	269,771
3/14/2023	Richard William Scalzo	Insider	Sell	1,311	$13.33	$17,475.63	54,872
3/14/2023	Susanna High	COO	Sell	1,559	$13.33	$20,781.47	110,476
1/18/2023	Jonathan Mcneill	Insider	Sell	10,000	$14.03	$140,300.00	67,600
1/9/2023	Jonathan Mcneill	Insider	Sell	30,150	$11.57	$348,835.50	67,600
12/12/2022	Jason P Rhodes	Director	Buy	934,581	$10.70	$10,000,016.70	934,581
12/12/2022	Richard William Scalzo	Insider	Sell	312	$10.87	$3,391.44	56,183
12/12/2022	Susanna High	COO	Sell	751	$10.87	$8,163.37	112,035
10/10/2022	Joshua T Brumm	Insider	Sell	195,800	$12.46	$2,439,668.00	204,623
10/7/2022	Joshua T Brumm	Insider	Sell	14,200	$13.37	$189,854.00	204,623

SEC Filings (Institutional Ownership Changes) for Dyne Therapeutics (NASDAQ:DYN)

96.68% of Dyne Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Dyne Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
6/18/2025	Voya Investment Management LLC	49,786	$0.52M	0.0%	-80.1%	0.044%
5/29/2025	Rhumbline Advisers	133,627	$1.40M	0.0%	+4.2%	0.118%
5/19/2025	Jane Street Group LLC	117,006	$1.22M	0.0%	-26.5%	0.103%
5/19/2025	Optimize Financial Inc	14,761	$0.15M	0.1%	N/A	0.013%
5/16/2025	Exome Asset Management LLC	258,391	$2.70M	2.3%	N/A	0.227%
5/16/2025	Caxton Associates LLP	14,972	$0.16M	0.0%	N/A	0.013%
5/16/2025	Voleon Capital Management LP	59,673	$0.62M	0.0%	N/A	0.052%
5/16/2025	Goldman Sachs Group Inc.	994,886	$10.41M	0.0%	+58.2%	0.875%
5/16/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	56,466	$0.60M	0.0%	+5.4%	0.050%
5/16/2025	AQR Capital Management LLC	23,560	$0.25M	0.0%	N/A	0.021%
5/16/2025	ADAR1 Capital Management LLC	30,099	$0.32M	0.1%	N/A	0.026%
5/15/2025	Vestal Point Capital LP	1,800,000	$18.83M	1.3%	N/A	1.584%
5/15/2025	RA Capital Management L.P.	9,714,392	$101.61M	1.7%	+52.2%	8.549%
5/15/2025	Frazier Life Sciences Management L.P.	1,443,341	$15.10M	0.7%	N/A	1.270%
5/15/2025	Palo Alto Investors LP	333,391	$3.49M	0.7%	N/A	0.293%
5/15/2025	PDT Partners LLC	224,176	$2.35M	0.2%	N/A	0.197%
5/15/2025	Braidwell LP	3,621,344	$37.88M	1.3%	+431.6%	3.187%
5/15/2025	Nantahala Capital Management LLC	345,062	$3.61M	0.1%	N/A	0.304%
5/15/2025	Cubist Systematic Strategies LLC	115,534	$1.21M	0.0%	-3.0%	0.102%
5/15/2025	Graham Capital Management L.P.	62,269	$0.65M	0.0%	N/A	0.055%
5/15/2025	Armistice Capital LLC	2,768,000	$28.95M	0.4%	+187.0%	2.436%
5/15/2025	Quarry LP	4,500	$47K	0.0%	N/A	0.004%
5/15/2025	Siren L.L.C.	2,717,987	$28.43M	1.6%	+101.7%	2.391%
5/15/2025	Trexquant Investment LP	334,443	$3.50M	0.0%	+166.7%	0.294%
5/14/2025	Rafferty Asset Management LLC	147,353	$1.54M	0.0%	-12.0%	0.130%
5/14/2025	Comerica Bank	41,176	$0.43M	0.0%	+16.3%	0.036%
5/14/2025	Walleye Capital LLC	154,634	$1.62M	0.0%	N/A	0.136%
5/14/2025	Atlas Venture Life Science Advisors LLC	9,130,465	$95.51M	18.3%	+13.9%	8.035%
5/14/2025	AlphaQuest LLC	16,332	$0.17M	0.0%	N/A	0.014%
5/14/2025	Candriam S.C.A.	463,368	$4.85M	0.0%	+15.4%	0.408%
5/14/2025	T. Rowe Price Investment Management Inc.	1,167,975	$12.22M	0.0%	N/A	1.028%
5/14/2025	Hsbc Holdings PLC	28,396	$0.29M	0.0%	+112.6%	0.025%
5/14/2025	Wellington Management Group LLP	36,322	$0.38M	0.0%	-5.8%	0.032%
5/13/2025	Algert Global LLC	476,007	$4.98M	0.1%	+488.2%	0.419%
5/13/2025	Aberdeen Group plc	314,586	$3.29M	0.0%	+1,119.2%	0.277%
5/13/2025	Fox Run Management L.L.C.	17,088	$0.18M	0.0%	N/A	0.015%
5/13/2025	E Fund Management Co. Ltd.	13,771	$0.14M	0.0%	+16.2%	0.012%
5/13/2025	Caitong International Asset Management Co. Ltd	3,092	$32K	0.0%	+378.6%	0.003%
5/13/2025	Russell Investments Group Ltd.	67,877	$0.71M	0.0%	-41.9%	0.060%
5/12/2025	Nuveen LLC	223,215	$2.34M	0.0%	N/A	0.196%
5/12/2025	Invesco Ltd.	66,293	$0.69M	0.0%	+64.4%	0.058%
5/12/2025	Swiss National Bank	118,300	$1.24M	0.0%	+8.9%	0.104%
5/9/2025	Deutsche Bank AG	317,664	$3.32M	0.0%	+347.7%	0.280%
5/9/2025	Charles Schwab Investment Management Inc.	654,131	$6.84M	0.0%	-2.0%	0.576%
5/9/2025	Vanguard Group Inc.	7,406,344	$77.47M	0.0%	+10.5%	6.518%
5/9/2025	Privium Fund Management B.V.	27,566	$0.29M	0.1%	+35.4%	0.024%
5/8/2025	Aegis Wealth Management LLC	33,228	$0.35M	0.2%	N/A	0.029%
5/8/2025	XTX Topco Ltd	31,574	$0.33M	0.0%	N/A	0.028%
5/8/2025	GSA Capital Partners LLP	98,597	$1.03M	0.1%	N/A	0.087%
5/7/2025	Zurcher Kantonalbank Zurich Cantonalbank	19,247	$0.20M	0.0%	+22.2%	0.017%
5/7/2025	TD Asset Management Inc	21,656	$0.23M	0.0%	-69.9%	0.019%
5/6/2025	Y Intercept Hong Kong Ltd	80,665	$0.84M	0.1%	+725.8%	0.071%
5/2/2025	Victory Capital Management Inc.	59,411	$0.62M	0.0%	-3.2%	0.052%
5/1/2025	Arizona State Retirement System	17,501	$0.18M	0.0%	+9.2%	0.015%
4/30/2025	China Universal Asset Management Co. Ltd.	22,690	$0.24M	0.0%	+5.2%	0.020%
4/29/2025	Bank of New York Mellon Corp	232,626	$2.43M	0.0%	-0.9%	0.205%
4/15/2025	SG Americas Securities LLC	430,051	$4.50M	0.0%	+2,159.1%	0.380%
4/8/2025	Rhumbline Advisers	133,627	$1.40M	0.0%	+4.2%	0.118%
4/7/2025	GAMMA Investing LLC	2,625	$0.25M	0.0%	+837.5%	0.002%
3/24/2025	Wellington Management Group LLP	38,550	$0.91M	0.0%	-7.5%	0.034%
2/19/2025	GF Fund Management CO. LTD.	2,137	$50K	0.0%	N/A	0.002%
2/18/2025	Neo Ivy Capital Management	8,715	$0.21M	0.0%	N/A	0.009%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	143,363	$3.38M	0.0%	+6.7%	0.141%
2/17/2025	Voloridge Investment Management LLC	119,015	$2.80M	0.0%	N/A	0.117%
2/17/2025	Woodline Partners LP	573,957	$13.52M	0.1%	-41.3%	0.564%
2/17/2025	Squarepoint Ops LLC	51,616	$1.22M	0.0%	-38.0%	0.051%
2/17/2025	Two Sigma Advisers LP	76,100	$1.79M	0.0%	+25.4%	0.075%
2/17/2025	Sphera Funds Management LTD.	236,262	$5.57M	1.0%	+318.1%	0.232%
2/17/2025	RTW Investments LP	5,218,641	$122.95M	1.9%	-23.5%	5.128%
2/17/2025	Rafferty Asset Management LLC	167,482	$3.95M	0.0%	+1.5%	0.165%
2/17/2025	Point72 Asset Management L.P.	924,681	$21.79M	0.0%	+802.3%	0.909%
2/17/2025	ProShare Advisors LLC	28,044	$0.66M	0.0%	+32.4%	0.028%
2/17/2025	Man Group plc	746,463	$17.59M	0.0%	+3.9%	0.733%
2/17/2025	Nuveen Asset Management LLC	266,404	$6.28M	0.0%	-3.6%	0.262%
2/17/2025	Orbimed Advisors LLC	1,227,080	$28.91M	0.6%	+73.2%	1.206%
2/17/2025	Octagon Capital Advisors LP	668,000	$15.74M	2.6%	+154.3%	0.656%
2/17/2025	Millennium Management LLC	37,536	$0.88M	0.0%	+526.5%	0.037%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	53,580	$1.26M	0.0%	+5.7%	0.053%
2/17/2025	Integral Health Asset Management LLC	150,000	$3.53M	0.3%	N/A	0.147%
2/17/2025	Janus Henderson Group PLC	7,379,309	$173.81M	0.1%	+8.3%	7.251%
2/17/2025	Jefferies Financial Group Inc.	1,800,000	$42.41M	0.2%	N/A	1.769%
2/17/2025	Ensign Peak Advisors Inc	315,602	$7.44M	0.0%	+0.9%	0.310%
2/17/2025	Farallon Capital Management LLC	229,121	$5.40M	0.0%	-46.5%	0.225%
2/17/2025	Fcpm Iii Services B.V.	5,462,846	$128.71M	21.8%	-8.3%	5.368%
2/17/2025	FORA Capital LLC	9,235	$0.22M	0.0%	-49.2%	0.009%
2/17/2025	Frontier Capital Management Co. LLC	298,052	$7.02M	0.1%	N/A	0.293%
2/17/2025	Deutsche Bank AG	70,961	$1.67M	0.0%	+51.4%	0.070%
2/17/2025	D. E. Shaw & Co. Inc.	133,772	$3.15M	0.0%	+83.1%	0.131%
2/17/2025	Deep Track Capital LP	2,000,000	$47.12M	1.8%	-39.1%	1.965%
2/17/2025	Crestline Management LP	184,818	$4.35M	0.1%	+57.0%	0.182%
2/17/2025	Cubist Systematic Strategies LLC	119,065	$2.81M	0.0%	N/A	0.117%
2/17/2025	Braidwell LP	681,182	$16.05M	0.5%	N/A	0.669%
2/17/2025	Brevan Howard Capital Management LP	28,781	$0.68M	0.0%	N/A	0.028%
2/17/2025	Balyasny Asset Management L.P.	169,306	$3.99M	0.0%	-30.9%	0.166%
2/17/2025	Bank of America Corp DE	122,641	$2.89M	0.0%	-58.0%	0.121%
2/17/2025	BNP Paribas Financial Markets	66,998	$1.58M	0.0%	N/A	0.066%
2/17/2025	Ameriprise Financial Inc.	219,635	$5.18M	0.0%	+3.2%	0.216%
2/17/2025	Algert Global LLC	80,923	$1.91M	0.0%	-14.8%	0.080%
2/17/2025	ArrowMark Colorado Holdings LLC	932,231	$21.96M	0.3%	+3.6%	0.916%
2/14/2025	Comerica Bank	35,409	$0.83M	0.0%	+20,133.7%	0.035%

Data available starting January 2016

Dyne Therapeutics, Inc., a clinical-stage muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. Dyne Therapeutics, Inc. was incorporated in 2017 and is headquartered in Waltham, Massachusetts.

Today's Range

Now: $8.94

$8.73

$9.22

50 Day Range

MA: $11.81

$8.68

$14.78

52 Week Range

Now: $8.94

$6.36

$47.45

Volume

5,557,831 shs

Average Volume

1,812,247 shs

Market Capitalization

$1.02 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.08

Who are the company insiders with the largest holdings of Dyne Therapeutics?: Dyne Therapeutics' top insider shareholders include:
Jason P Rhodes (Director)
Venture Fund Xi LP Atlas (Major Shareholder)
Dirk Kersten (Director)
Joshua T Brumm (CEO)
Oxana Beskrovnaya (Insider)
Susanna Gatti High (COO)
Wildon Farwell (Insider)
Jonathan Mcneill (Insider)
Richard William Scalzo (Insider)
Richard William Scalzo (SVP)
Johanna Friedl-Naderer (Insider)
John Cox (CEO)
Carlo Incerti (Director)
Learn More about top insider investors at Dyne Therapeutics.